ProteinSimple today introduced Wes, another revolutionary re-invention of the Western blot. Wes is the bold evolution of the popular Simple Western family of instruments, delivering simplicity and performance like no product before it. With just 30 minutes of sample prep, Wes will analyze up to 25 samples in under 3 hours and he will do it all for less than the price of a high-end Western imager. Wes also introduces an innovative suite of consumables that streamline assay workflow and delivers sensitivity that is better than any traditional Western.
When the Simple Western launched in 2011, it changed the Western blot world forever. It eliminated the hassles of traditional Western blots—no more messy gels, no transfer tanks, no blots, no imaging and no manual analysis. All the steps of the Simple Western are automated, and quantitative data is delivered in a matter of hours.
Wes elevates the Simple Western platform to a stunning level of simplicity. Wes assay kits come with a microplate pre-filled with all the required reagents, fully prepared and ready to use. Researchers only need to pipette their sample and primary antibody into the microplate. Then, simply insert the plate and a disposable capillary cartridge into the instrument. From there, Wes runs the chosen assay and delivers fully analyzed data. The researcher can then dispose of the plate and cartridge and Wes is completely ready for the next experiment.
Wes not only makes running a Simple Western even easier than ever, he also significantly improves performance. Wes delivers at least 10 times more sensitivity than first generation Simple Western instruments without sacrificing any precision for which the Simple Western assay is known. Wes can now outperform any traditional Western not only in terms of time, but also sensitivity.
"Wes changes the game entirely," commented Tim Harkness, CEO of ProteinSimple. "He delivers on our promise to drive simplicity into protein research and is positioned to deliver that simplicity to every laboratory in the world that is running Western blots today."